Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

9.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aβ Modulates Extracellular Vesicles Proteomic Profile Impacting Phosphorylation Mediators.

Molecular neurobiology·2025
Same author

Repairing spinal cord injuries: The most promising polymeric biomaterials and local drug delivery.

Neural regeneration research·2025
Same author

Neuroprotection by Mitochondrial NAD Against Glutamate-Induced Excitotoxicity.

Cells·2025
Same author

Fourier Transform Infrared Spectroscopy Analysis as a Tool to Address Aβ Impact on Extracellular Vesicles.

Molecules (Basel, Switzerland)·2025
Same author

LAP1 Interactome Profiling Provides New Insights into LAP1's Physiological Functions.

International journal of molecular sciences·2025
Same author

Phosphoproteome Microarray Analysis of Extracellular Particles as a Tool to Explore Novel Biomarker Candidates for Alzheimer's Disease.

International journal of molecular sciences·2024

Related Experiment Video

Updated: May 22, 2025

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
06:49

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans

Published on: December 17, 2021

2.8K

Comparing In vitro Protein Aggregation Modelling Using Strategies Relevant to Neuropathologies.

André Nadais1, Inês Martins1, Ana Gabriela Henriques1

  • 1Neurosciences and Signaling Group, Department of Medical Sciences, Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal.

Cellular and Molecular Neurobiology
|March 13, 2025
PubMed
Summary

This study compares four in vitro models for protein aggregation, finding distinct differences in aggregate formation and cellular responses. These models offer valuable tools for studying neurodegenerative diseases like Alzheimer's and Parkinson's.

Keywords:
Alzheimer´s diseaseAβ1-42 peptideMitochondrial dysfunctionParkinson´s diseaseProtein aggregation

More Related Videos

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.4K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

5.8K

Related Experiment Videos

Last Updated: May 22, 2025

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
06:49

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans

Published on: December 17, 2021

2.8K
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.4K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

5.8K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Protein aggregation is a hallmark of neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD).
  • AD involves tau and amyloid-beta (Aβ) pathology, while PD is characterized by alpha-synuclein aggregation.
  • Developing reliable in vitro models is crucial for understanding these diseases.

Purpose of the Study:

  • To compare four distinct in vitro models for studying protein aggregation.
  • To evaluate their effectiveness in inducing aggregation-relevant events in human neural cells.
  • To identify model-specific differences in aggregate formation and cellular responses.

Main Methods:

  • Utilized the human neural SH-SY5Y cell line.
  • Applied four different treatments to induce protein aggregation: toxic Aβ1-42 peptide, rotenone, oligomycin, and MG-132.
  • Analyzed aggregate formation, chaperone expression (HSP-70), and protein phosphorylation.

Main Results:

  • All treatments induced aggregation-relevant events, but with significant model-dependent variations.
  • Aβ1-42 peptide and MG-132 showed the strongest aggregate-promoting effects.
  • MG-132 uniquely increased HSP-70 chaperone expression, and protein phosphorylation was linked to aggregate formation.
  • Aβ exposure modeled AD, while rotenone effectively modeled PD, with tau co-localizing in the Aβ model.

Conclusions:

  • Distinct in vitro models elicit different molecular processes, including protein aggregation and proteostatic modulation.
  • These models serve as valuable tools for investigating specific protein-aggregation-related mechanisms in distinct neuropathologies.
  • The choice of model influences the type of aggregates formed and cellular responses, aiding targeted research in neurodegenerative diseases.